20
Zydus Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CLINDAMYCIN PHOSPHATE USP, with a corresponding US DMF Number 26669.
Remarkably, this DMF maintains an Active status since its submission on March 10, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 16, 2015, and payment made on March 04, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II